On the way to deprescribing levothyroxine in subclinical hypothyroidism in general practice – the patients’ perspective of enablers and barriers
Patients wished for medical information to reduce their doubts concerning deprescribing and expressed confidence in their general practitioner. Our findings indicate a fundamental commitment to deprescribing LTX. For an adherent process in general practitioners' practices, a strategy that considers patients' worries and concerns seems feasible.
Authors
- Anne-Kathrin Geier (ORCID: https://orcid.org/0009-0003-4697-2809)
- Karen Voigt (ORCID: https://orcid.org/0000-0003-2246-7368)
- Tobias Deutsch (ORCID: https://orcid.org/0000-0002-0936-6282)
- Markus Bleckwenn (ORCID: https://orcid.org/0000-0003-1975-5369)
- Susanne Scheibe (ORCID: https://orcid.org/0000-0003-1001-6199)
- Christine Saluzzo (ORCID: https://orcid.org/0000-0003-4997-4650)
- M Rennert (ORCID: https://orcid.org/0009-0003-2949-2248)
- Jeannine Schübel
- Steven Hager
- Annika Rettich (ORCID: https://orcid.org/0009-0005-5370-6896)
Institutions
- University Hospital Carl Gustav Carus (DE)
- Leipzig University (DE)
Publication Details
- Journal
- European Journal of General Practice
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1080/13814788.2025.2571605
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00